• Users Online: 346
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2018  |  Volume : 4  |  Issue : 3  |  Page : 159-163

Immunosuppression for postcardiac transplant patients

Department of Cardiology, AIIMS, New Delhi, India

Correspondence Address:
Dr. Dhara Singh
AIIMS, New Delhi
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jpcs.jpcs_56_18

Rights and Permissions

After the introduction of immunosuppressive drugs in the management of postheart transplant patients, the incidence of rejection has decreased significantly resulted in improvement in mortality and long-term outcome. Induction regimens provide intense early postoperative immune suppression while maintenance regimens are used throughout the patient's life to prevent both acute and chronic rejection. An immunosuppressive regimen tailored individually for each patient will help in decreasing the incidence of adverse events and complications. A complete understanding of currently available immunosuppressive agents is therefore essential.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded578    
    Comments [Add]    
    Cited by others 1    

Recommend this journal